Skip to content

Effect of peppermint aroma on the severity of nausea and vomiting of pregnancy

Determination the effect of inhaled peppermint aroma on the severity of nausea and vomiting of pregnancy in women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201412043860N9
Enrollment
64
Registered
2014-12-31
Start date
2015-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting of pregnancy. Mild hyperemesis gravidarum

Interventions

Intervention 1: Intervention group: In this group, Aromatherapy with Peppermint essential oil will be done for 4 days. Pregnant women will inhale 1 milliliter of bottle content (containing 2 drops of
Treatment - Drugs
Placebo
Intervention group: In this group, Aromatherapy with Peppermint essential oil will be done for 4 days. Pregnant women will inhale 1 milliliter of bottle content (containing 2 drops of peppermint esse
Control group: The method of aromatherapy in the control group will be the same as intervention group with the difference that in this group sweet almond oil will be used alone.

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: nclusion criteria: Age 18-35 years, Iranian and has the ability to read and write, Basic severity of nausea and vomiting according to (PUQE) questionnaire before intervention in range mild to moderate (score 3-12), 6 to 20 weeks of gestational age (based on the first day of the last menstrual period or first trimester sonography), Having at least one sonography to determine the number and health of the fetus, Wanted pregnancy, The lack of sense of smell problems, A normal single pregnancy in every respect and without a history of obstetric complications during pregnancy (no symptoms of threatened abortion, lack of molar pregnancy), Healthy pregnant women without a history of known diseases according to the information in the maternal health file, Non-smoker and non-alcoholic, Lack of sensitivity to herbal medicines according to her, Avoiding the use of any chemical or herbal antiemetics during the 24 hours before the start of study, Lack of mental health problems and disaster during the six months before the start of study according to her. Exclusion criteria: Severe nausea and vomiting of pregnancy (scoring 13 or higher according to PUQE questionnaire)during the study period, Allergic to peppermint essential oil or peppermint fragrance intolerance, Use any chemical or herbal antiemetics, Aromatherapy less than three times during the day, Signs and symptoms of threatened abortion during the study period, Unwillingness to continue to participate in the studExclusion criteria: severe nausea and vomiting of pregnancy (scoring 13 or higher according to PUQE questionnaire), allergic to peppermint oil or peppermint fragrance intolerance, use any chemical or herbal anti-nausea medication, signs and symptoms of threatened abortion during the study period, unwillingness to continue to participate in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of nausea and vomiting of pregnancy. Timepoint: Before the intervention, after the intervention at the end of each day for 4 days. Method of measurement: The Pregnancy Unique Quantification of Emesis/Nausea questionnaire.

Secondary

MeasureTime frame
Satisfaction of the treatment course. Timepoint: At the end of intervention period ( after 4 days). Method of measurement: Researcher made questionnaire at the end of intervention.;Possible side effects of intervention. Timepoint: At the end of intervention period ( after 4 days). Method of measurement: Researcher made questionnaire at the end of intervention.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNarges Joulaee rad

Nursing and Midwifery college of Shahid Beheshti University of Medical Sciences

sbnmf@sbmu.ac.ir ; n.joulaeerad@yahoo.com+98 21 8865 5366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026